Valdés SO

Language: Spanish
References: 18
Page: 235-245
PDF size: 367.53 Kb.

ABSTRACT

Introduction: Sepsis constitutes a serious health problem in the entire world. In this moment, more than 1.4 millions of persons in the entire planet are suffering for nosocomial infections.
Objective: To investigate the theoretically knowledge of health professionals about septic syndrome and the use of antimicrobials.
Method: We performed a descriptive, evaluative, prospective study which anonymously and voluntarily surveyed 55 health professionals from different branches of Medical Sciences and different places (or level of care) where they work. Regarding professions the respondents were 18 physicians, 12 nurses, 3 students and 22 unclassified.
Results: Primary health care and those with unknown work place were the main groups with 43.6% and 40% respectively, of participation in the survey. Among the topics that were surveyed, 62.1% of the enquiries were incorrectly answered in relation to hand washing, 51.6% failed to answer the proper technique and applications of blood culture and 21% of the questions were not filled on the issue of antimicrobial use.
Conclusions: Professionals in primary health care have more demonstrated knowledge regarding general topics on septic syndromes with 54.2% correct answers. With this study we aim to contribute to the campaign against superbugs, sepsis and appropriate antimicrobial use that is neither always done correctly nor guided by knowledge, theoretical definitions and scientifically based. That was reflected in the results of our work.

REFERENCES

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.

2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.

3. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis ocurring in the first 24 hours in intensive care units in England, Wales and Northern Ireland. Crit Care Med. 2003;31:2332-8.

4. American College of Chest Physicians/Society of Critical Care Medicine. American College of Chest Physicians/Society of Critical Care Medicine consensus conference; definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992 Jun;101(6):1644-55.

5. Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Critical Care. 2009;13:R167.

6. Dobesh PP, Swahn SM, Peterson EJ, Keith M, Olsen KM. Statins in Sepsis. Journal of Pharmacy Practice. 2010;23(1):38-49.

7. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17–60.

8. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.

9. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign Guidelines for the management of severe sepsis and septic shock. Intensive Care Med. 2004;30:536-555.

10. Masson P, Matheson S, Webster AC, Craig JC. Meta-analyses in prevention and treatment of urinary tract infections. Infect Dis Clin North Am. 2009;23:355-85.

11. Barie PS, Eachempati SR. Surgical site infections. Surg Clin North Am. 2005;85: 115-35.

12. Serna MC. Determinantes de la prescripción de antibióticos en atención primaria. Enferm Infecc Microbiol Clin. 2011;29(3):193-200.

13. Aronson MD. Bor DH. Diagnosis and treatment. Diagnostic decision. Blood Cultures. Ann Intern Med. 1987;106:246-53.

14. Arpi M, Bentzon MW, Jensen J, Frederiksen W. Importance of blood volume cultured in the detectión of bacteriemia. Fur J Clin Microbiol Infect Dis. 1989;8:838-842.

15. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113:227-242.

16. Bouza E, Díaz-López MD, Moreno S. Bernaldo de Quirós JC, Vicente T, Berenguer J. Mycobacreriurn tuberculosis bacteremia in patients with and without Human Inmunodeficiency Virus Infection. Arch Intern Med. 1993;153:496-500.

17. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739.

18. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Critical Care. 2010;14:R15.